Janoshik Lab
Lab Result: Cartalax 25mg
(Batch CAR01)
Avg. purity
99.525%
Avg. mass:
25.24 mg
Result Date
December 18, 2025
Date added
February 14, 2026
Each vial contains 25mg of highly pure Cartalax in lyophilized form.
Cartalax is a chondroprotective product formulated to support joint health and mobility. It contains bioactive compounds that promote cartilage regeneration, reduce inflammation, and help restore normal joint function in cases of arthritis, trauma, or degenerative joint conditions. Designed for intramuscular or intra-articular administration under professional supervision.
Add 2.5mL of bacteriostatic water to get a solution that is 10mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 1mg of Cartalax.
This product must be refrigerated after reconstitution.